Hepatocyte growth factor and c-Met expression in pericytes: Implications for atherosclerotic plaque development

Journal of Pathology

Volumn 212, Issue 1, 2007, Pages 12-19

  Liu, Y ^a   Wilkinson, F L ^a   Kirton, J P ^a,b   Jeziorska, M ^a   Iizasa, H ^c   Sai, Y ^c   Nakashima, E ^c   Heagerty, A M ^a   Canfield, A E ^a,b   Alexander, M Y ^a   Alexander, M Yvonne ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; c Met; Hepatocyte growth factor; Neovascularization; Pericyte

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACTIN; CD31 ANTIGEN; PROTEIN SERINE THREONINE KINASE; PROTEIN SM; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLEEDING; CELL LINE; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIMB AMPUTATION; MAMMARY ARTERY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CAPILLARIES; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; ENZYME ACTIVATION; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PROTO-ONCOGENE PROTEINS C-MET; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34248529664     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2155     Document Type: Article

References (33)

1. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 2002;8:1257-1262.
2. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003;100:4736-4741.
3. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-2061.
4. Cipollone F, Fazia M, Mezzetti A. Novel determinants of plaque, instability. J Thromb Haemost 2005;3:1962-1975.
5. Andreeva ER, Pugach IM, Gordon D, Orekhov AN. Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell 1998;30:127-135.
6. Bostrom K, Watson KE, Horn S, Wortham C, Herman I, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-1809.
7. Ivanov D, Philippova M, Antropova J, Gubaeva F, Iljinskaya O, Tararak E, et al. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol 2001;115:231-242.
8. Collett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 2005;96:930-938.
9. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K, et al. Multilineage potential of cells from the artery wall. Circulation 2003;108:2505-2510.
10. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tiss Res 2003;314:15-23.
11. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endo Metab 2004; 286:E686-696.
12. Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Min Res 1998;13:828-838.
13. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
14. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-804.
15. VanBelle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998; 97:381-390.
16. Gerritsen ME. HGF and VEGF: a dynamic duo. Circ Res 2005; 96:272-273.
17. Ma H, Calderon TM, Fallon JT, Berman JW. Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques. Atherosclerosis 2002;164:79-87.
18. McKinnon H, Gherardi E, Reidy M, Bowyer D. Hepatocyte growth factor/ scatter factor and MET are involved in arterial repair and atherogenesis. Am J Pathol 2006;168:340-348.
19. Asashima T, Izasa H, Terasaki T, Hosoya K, Tetsuka K, Ueda M, et al. Newly developed rat brain pericyte cell line, TR-PCT1, responds to transforming growth factor-beta 1 and beta-glycerophosphate. Eur J Cell Biol 2002;81:145-152.
20. Nayak RC, Berman AB, George KL, Eisenbarth GS, King GL. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med 1988; 167:1003-1015.
21. Julke M, von SL, Schneider J, Turina M, Heitz PU. Degree of arteriosclerosis of the internal mammary artery and of the coronary arteries in 45-75 year-old men. An autopsy study. Schweiz Med Wochenschr 1989;119:1219-1223.
22. Alexander MY, Wilkinson FL, Kirton JP, Rock CF, Collett GDM, Jeziorska M, et al. Identification and characterization of vascular calcification-associated factor, a novel gene upregulated during vascular calcification in vitro and in vivo. Arterioscler Thromb Vasc Biol 2005;25:1851-1857.
23. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
24. Wajih N, Sane DC. Angiostatin selectively inhibits signalling by hepatocyte growth factor in endothelial and smooth muscle cells. Blood 2003;101:1857-1863.
25. Royal I, Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem 1995;270:27 780-27 787.
26. Ma H, Calderon TM, Kessel T, Ashton AW, Berman JW. Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration. Circ Res 2003;93:1066-1073.
27. Taher TEI, Derksen PWB, De Boer OJ, Spaargaren M, Teeling P, Van der Wal AC, et al. Hepatocyte growth factor triggers signalling cascades mediating vascular smooth muscle cell migration. Biochem Biophys Res Commun 2002;298:80-86.
28. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 2005;24:7443-7454.
29. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-641.
30. Haug C, Lenz C, Bachem MG. Oxidized LDL inhibit hepatocyte growth factor synthesis in coronary smooth muscle cells. Int J Cardiol 2005; 103:298-306.
31. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704-1709.
32. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity - patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 1998;18:333-338.
33. Demer LL, Tintut Y. Return to ectopia: stem cells in the artery wall. Arterioscler Thromb Vasc Biol 2005;25:1307-1308.